BioSight vs PhaseV
BioSight vs PhaseV, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BioSight is on 37/100 and PhaseV on 56/100.
Where each one leads
BioSight
Leads on none of the measures we hold for both companies.
PhaseV
- our overall score: 56/100 against 37/100
- domain rating: 33/100 against 12/100
- headcount: 61 against 3
- headcount growth: +173.2% against -30.1%
- funding raised: $65.0M against $1.5M
- LinkedIn following: 6,602 against 681
At a glance
| Measure | BioSight | PhaseV |
|---|---|---|
| What it is | Clinical-stage biotech developing novel therapeutics for hematological malignancies and disorders. | Develops a platform for adaptive clinical trial design and closed-loop execution. |
| Category | Life Sciences, Biotech, MedTech, HealthTech | Life Sciences, Clinical Trials, Optimization, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Software |
| Founded | 1999 | 2023 |
| Headquarters | Tel Aviv, Israel | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | BioSight | PhaseV |
|---|---|---|
| Employees | 3 | 61 |
| Headcount growthLast 12 months | -30.1% | +173.2% |
| Total funding | $1.5M | $65.0M |
| Latest round | Not published | Series A |
| LinkedIn followers | 681 | 6,602 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BioSight | PhaseV |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 37/100 | 56/100 |
| Traction | 37/100 | 57/100 |
| Team | Not published | 70/100 |
| Search visibility | 32/100 | 40/100 |
| Quality | 45/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (46/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 12/100 | 33/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BioSight | PhaseV |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Wix | Webflow |
| Analytics | Not detected | Google Analytics 4 |
BioSight vs PhaseV: common questions
Which is better, BioSight or PhaseV?
On our 0-100 score PhaseV rates higher (56/100 against 37/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do BioSight and PhaseV compare on the numbers?
PhaseV leads on our overall score (56/100 against 37/100), domain rating (33/100 against 12/100), headcount (61 against 3), headcount growth (+173.2% against -30.1%), funding raised ($65.0M against $1.5M), LinkedIn following (6,602 against 681).
Read the full BioSight review and pricing or the PhaseV review and pricing. You can also browse other BioSight alternatives we track.